Mark Mendonca

Mark Mendonca is a Senior Manager in Medical Operations at CSL, where they oversee medical strategy for pipeline programs and manage evidence generation projects. Previously, they served as a Senior Associate Scientist at The Janssen Pharmaceutical Companies, focusing on preclinical development of innovative monoclonal antibodies. Mark's early career includes roles as a Research Technician at Thomas Jefferson University and an IRTA Fellow at the National Institutes of Health, where they specialized in immunology and analytical techniques. They also contributed significantly to the development of iPSC-derived T/NK cell programs at Century Therapeutics.